Recruiting
A Study Assessing the Drug Levels, Drug Effects, and Safety of BMS-986322 in Healthy Participants - IM032-007
Updated: 21 November, 2019 | ClinicalTrials.gov
Print Friendly Summary
Trial Details
Phase
Gender(s)
Age Range
Location(s)
Recruiting
Treatment Options
For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com Inclusion Criteria: - Healthy Participant, as determined by no clinically significant deviation from normal in medical history, physical examination, ECGs, and clinical laboratory determinations - Body mass index (BMI) of 18.0 kg/m^2 to 32.0 kg/m^2, inclusive, and body weight ≥ 50 kg, at screening - Women and men must agree to follow methods of contraception. Exclusion Criteria: - Any significant acute or chronic medical illness - History of recent infection - History of allergy to BMS-986322 or other compounds Other protocol-defined inclusion/exclusion criteria could apply.
We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information
